Cash And Equivalent Zmiana Data
AbbVie USD 5.18B 349M 2025-03
Alcon AG USD 1.41B 417M 2025-03
Almirall EUR 374.4M 2.7M 2025-03
Amgen USD 8.81B 3.16B 2025-03
AstraZeneca USD 7.06B 1.83B 2025-06
Bayer EUR 4.02B 2.18B 2025-03
Biogen USD 2.76B 160.5M 2025-06
Bristol-Myers Squibb USD 12.6B 1.72B 2025-06
Eli Lilly USD 3.09B 175.1M 2025-03
Fresenius EUR 2.39B 105M 2025-03
Fresenius Medical Care EUR 1.07B 109M 2025-03
Galapagos EUR 108.07M 43.83M 2025-03
Genmab DKK 1.62B 8.24B 2025-03
Gilead Sciences USD 7.93B 2.06B 2025-03
GlaxoSmithKline GBP 3.6B 865M 2025-06
GRIFOLS EUR 558.69M 194.13M 2025-06
Hikma Pharmaceutical USD 188M 188M 2024-12
Lonza CHF 1.11B 286M 2024-12
Merck EUR 1.01B 1.14B 2025-03
Merck USD 8.63B 4.61B 2025-03
Novartis USD 6.66B 410M 2025-06
Orion EUR 259.4M 53.8M 2025-03
Pfizer USD 1.43B 387M 2025-03
Philips EUR 1.19B 1.21B 2025-03
Recordati EUR 333.04M 98.02M 2025-03
Regeneron Pharmaceuticals USD 3.09B 14.82B 2025-03
Roche Holding CHF 6.98B 2.15B 2024-12
Sanofi 7.99B 550M 2025-03
UCB EUR 1.57B 1.14B 2024-12


Roche Holding Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Aug 2025.